cannabis indica

Índice completo — página 26 de 77

Estudos 2.501 a 2.600 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2021. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 2.501 a 2.600

  1. 2021

    Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies

    FavorávelMetanáliseCâncerInflamaçãoEstresse OxidativoFicocianina
  2. 2021

    Phycocyanin inhibits pancreatic cancer metastasis via suppressing epithelial-mesenchymal transition and targeting Akt/β-catenin pathway

    FavorávelEstudo em AnimaisCâncerCâncer — MetastáticoCâncer — PâncreasFicocianina
  3. 2021

    Phycocyanobilin is the molecule responsible for the nephroprotective action of phycocyanin in acute kidney injury caused by mercury

    FavorávelEstudo em AnimaisInsuficiência RenalFicocianina
  4. 2021

    Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment

    InconclusivoMetanálisePsicoseEsquizofreniaEndocanabinoide (não especificado)
  5. 2021

    Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment

  6. 2021

    Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases

  7. 2021

    Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells

    FavorávelEstudo LaboratorialCâncer
  8. 2021

    Phytol suppresses parasitemia and ameliorates anaemia and oxidative brain damage in mice infected with Plasmodium berghei

    FavorávelEstudo em AnimaisMalária
  9. 2021

    Piloting a brief intervention plus mobile boosters for drug use among emerging adults receiving emergency department care

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  10. 2021

    Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation

    FavorávelEstudo LaboratorialDiabetesSíndrome Metabólica
  11. 2021

    Plasma and joint tissue pharmacokinetics of two doses of oral cannabidiol oil in guinea pigs (Cavia porcellus)

    InconclusivoEstudo em AnimaisArtrite
  12. 2021

    Plasmatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis

  13. 2021

    Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

  14. 2021

    Polyphenols and Cannabidiol Modulate Transcriptional Regulation of Th1/Th2 Inflammatory Genes Related to Canine Atopic Dermatitis

    FavorávelEstudo LaboratorialInflamaçãoAplicações VeterináriasDoenças de Pele
  15. 2021

    Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway

    FavorávelMetanáliseInflamaçãoEstresse OxidativoTOC
  16. 2021

    Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol

    FavorávelMetanáliseCâncer
  17. 2021

    Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis

  18. 2021

    Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy

    InconclusivoMetanáliseDoença de Alzheimer
  19. 2021

    Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series

    FavorávelMetanáliseEpilepsia
  20. 2021

    Potential of cannabinoids as treatments for autism spectrum disorders

    FavorávelMetanáliseAutismo
  21. 2021

    Potential role of cannabidiol in Parkinson’s disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation

    FavorávelMetanáliseInflamaçãoEstresse OxidativoDoenças Neurodegenerativas+1
  22. 2021

    Potential Role of Cannabidiol on Sports Recovery: A Narrative Review

    FavorávelMetanáliseDorAnsiedadeDisfunção Cognitiva+3
  23. 2021

    Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials

    InconclusivoMetanálise ClínicaAnsiedadeEsquizofreniaDependência — Nicotina+7
  24. 2021

    Potential therapeutic uses of cannabinoids to treat behavioural problems in children and adolescents with developmental disorders

    FavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+9
  25. 2021

    PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice

    FavorávelEstudo em AnimaisInflamaçãoDisfunção CognitivaPsicose+1
  26. 2021

    Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain

    FavorávelMetanáliseDorDor — CrônicaDependência — Opioides
  27. 2021

    Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome

    FavorávelEstudo em AnimaisEpilepsiaEpilepsia — Síndrome de Dravet
  28. 2021

    Predictors and moderators of marijuana and heavy alcohol use outcomes in adolescents treated for co-occurring substance use and psychiatric disorders in a randomized controlled trial

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisPsicose+1
  29. 2021

    Predictors of substance use in a clinical sample of youth seeking treatment for Trauma-related mental health problems

    InconclusivoEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+1
  30. 2021

    Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities

    DesfavorávelMetanáliseGestaçãoTetraidrocanabinol (THC)
  31. 2021

    Prenatal cannabis use disorders and offspring primary and secondary educational outcomes

    InconclusivoMetanáliseEfeitos Adversos da CannabisDisfunção CognitivaGestação+1
  32. 2021

    Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III)

  33. 2021

    Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV

    DesfavorávelMetanáliseDorDependência — CannabisDor — Crônica+1
  34. 2021

    Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+3
  35. 2021

    Prevalence, sociodemographic variables, mental health condition, and type of drug use associated with suicide behaviors among people with substance use disorders: a systematic review and meta-analysis

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisDepressão+6
  36. 2021

    Preventive Effect of Eucalyptol on the Formation of Aorta Lesions in the Diabetic-Atherosclerotic Rat

    FavorávelEstudo em AnimaisInflamaçãoDoenças Cardiovasculares (DCV)Estresse Oxidativo+1
  37. 2021

    Preventive interventions targeting cannabis use and related harms in people with psychosis: A systematic review

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisPsicose
  38. 2021

    Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019

    FavorávelMetanáliseAcneHidradenite Supurativa
  39. 2021

    Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review

    FavorávelMetanáliseAVC
  40. 2021

    Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases

  41. 2021

    Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain

    DesfavorávelMetanáliseDorDependência QuímicaDependência — Cannabis+1
  42. 2021

    Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients

    FavorávelMetanáliseDorDor — CrônicaDependência — Opioides
  43. 2021

    Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies

  44. 2021

    Prosocial Effects of Nonpsychotropic Cannabis sativa in Mice

    FavorávelEstudo em AnimaisAnsiedadeTranstornos de Comportamento
  45. 2021

    Prospects for the Use of Cannabinoids in Psychiatric Disorders

    InconclusivoMetanáliseAnsiedadeDepressãoInsônia e Distúrbios do Sono+1
  46. 2021

    Protective effects of anandamide against cisplatin-induced peripheral neuropathy in rats

  47. 2021

    Protective effects of cannabidiol on the membrane proteins of skin keratinocytes exposed to hydrogen peroxide via participation in the proteostasis network

    FavorávelEstudo LaboratorialInflamaçãoEstresse Oxidativo
  48. 2021

    Protective Effects of Cannabidiol on the Membrane Proteome of UVB-Irradiated Keratinocytes

    FavorávelEstudo LaboratorialEstresse OxidativoQueimadura Solar
  49. 2021

    Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions

  50. 2021

    Protective role of endocannabinoid signaling in an animal model of haloperidol-induced tardive dyskinesia

    FavorávelEstudo em AnimaisDistoniaCoreiaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  51. 2021

    Protein Kinases Mediate Anti-Inflammatory Effects of Cannabidiol and Estradiol Against High Glucose in Cardiac Sodium Channels

    FavorávelEstudo LaboratorialInflamaçãoDoenças Cardiovasculares (DCV)Estresse Oxidativo+2
  52. 2021

    Psychedelics for Brain Injury: A Mini-Review

    FavorávelMetanáliseEstresse OxidativoAVCTraumatismo Cranioencefálico
  53. 2021

    Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders

  54. 2021

    Psychological and endocannabinoid responses to aerobic exercise in substance use disorder patients

  55. 2021

    Psychosis induced by abuse of ayahuasca: a case report

    DesfavorávelMetanáliseAnsiedadeDepressãoPsicoseAyahuasca+2
  56. 2021

    Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisAnsiedade+2
  57. 2021

    Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis

    DesfavorávelEnsaio Clínico Duplo-CegoPsicoseCanabinoides Sintéticos JWH-x
  58. 2021

    Public health impact of daily life triggers of sudden cardiac death: A systematic review and comparative risk assessment

  59. 2021

    Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  60. 2021

    Purified Cannabidiol isolate does not inhibit active caspase-1 release in NLRP inflammasome-mediated UVB or ATP-activated keratinocytes or appear to reduce key inflammatory cytokines in UVB-irradiate keratinocytes

    InconclusivoEstudo LaboratorialCâncerInflamaçãoCâncer — Pele (não melanoma)
  61. 2021

    QTc prolongation in cannabis hyperemesis syndrome patients exposed to antiemetics: A retrospective chart review

  62. 2021

    Quality of Life and a Surveillant Endocannabinoid System

  63. 2021

    Quantitation of Δ8-THC, Δ9-THC, Cannabidiol, and Ten Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS/MS

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabinol (CBN)+4
  64. 2021

    Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus

    FavorávelEstudo LaboratorialGripe
  65. 2021

    Quetiapine treatment for cannabis use disorder

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis
  66. 2021

    Race, psychosocial characteristics, and treatment outcomes among individuals undergoing treatment for cannabis use disorder: A latent profile analysis based on preferred method of using cannabis

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — Cannabis
  67. 2021

    Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results

    FavorávelEnsaio ClínicoCOVID-19Palmitoiletanolamida (PEA)
  68. 2021

    Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs

    InconclusivoEstudo em AnimaisAplicações Veterinárias
  69. 2021

    Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial

    FavorávelEnsaio ClínicoDepressãoTentativa de SuicídioAyahuasca
  70. 2021

    Rates of self-directed perioperative cannabidiol use in patients undergoing total hip or knee arthroplasty

    InconclusivoMetanáliseDorDor — Aguda
  71. 2021

    Reaching nontreatment-seeking cannabis users: Testing an extended marijuana check-up intervention

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  72. 2021

    Real-Time Imaging of Immune Modulation by Cannabinoids Using Intravital Fluorescence Microscopy

    FavorávelMetanáliseInflamaçãoDiabetesArtrite+3
  73. 2021

    Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems

    FavorávelMetanáliseAnsiedadeInsônia e Distúrbios do Sono
  74. 2021

    Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users

    InconclusivoMetanáliseAnsiedadeEstresse OxidativoInsônia e Distúrbios do Sono
  75. 2021

    Recent Advances in Antioxidant Polymers: From Sustainable and Natural Monomers to Synthesis and Applications

    InconclusivoMetanáliseEstresse Oxidativo
  76. 2021

    Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases

  77. 2021

    Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System

    FavorávelMetanáliseCâncer
  78. 2021

    Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder

    InconclusivoMetanáliseAutismo
  79. 2021

    Recent updates on bioactive properties of linalool

    FavorávelMetanáliseCâncerAnsiedadeDepressão+2
  80. 2021

    Recreational cannabis laws and opioid-related emergency department visit rates

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  81. 2021

    Recreational cannabis legalization and alcohol purchasing: a difference-in-differences analysis

    InconclusivoMetanáliseDependência QuímicaDependência — Álcool
  82. 2021

    Recreational cannabis use causing non-ischaemic cardiomyopathy and cardioembolism in a young adult

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)AVC
  83. 2021

    Reducing Effect of Cannabidiol on Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Álcool
  84. 2021

    Reevaluating America's Latest Pharmaceutical Trend: The Cardiovascular Risk of Cannabis

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)
  85. 2021

    Regulatory Effect of Cannabidiol (CBD) on Decreased β-Catenin Expression in Alopecia Models by Testosterone and PMA Treatment in Dermal Papilla Cells

    FavorávelEstudo LaboratorialQueda de CabeloCrescimento Anormal de Pelos
  86. 2021

    Regulatory Effects of Cannabidiol on Mitochondrial Functions: A Review

    InconclusivoMetanáliseEstresse Oxidativo
  87. 2021

    Relationship between cannabis use and psychotic experiences in college students

    DesfavorávelMetanálisePsicose
  88. 2021

    Relationships between age at first substance use and persistence of cannabis use and cannabis use disorder

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  89. 2021

    Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies

    FavorávelMetanáliseCâncerInflamação
  90. 2021

    Response to 'Fool’s gold: diseased marijuana and cannabis hyperemesis syndrome'

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  91. 2021

    Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisTranstorno Bipolar
  92. 2021

    Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome

  93. 2021

    Reverse Takotsubo Cardiomyopathy Precipitated by Chronic Cocaine and Cannabis Use

  94. 2021

    Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement

    DesfavorávelMetanáliseAnsiedadeDisfunção CognitivaPsicose+2
  95. 2021

    Risk and benefit of cannabis prescription for chronic non-cancer pain

    FavorávelMetanáliseDorDependência QuímicaDor — Crônica+1
  96. 2021

    Risk and protective factors for cannabis, cocaine, and opioid use disorders: An umbrella review of meta-analyses of observational studies

  97. 2021

    Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders

  98. 2021

    Role of cannabinoids in alcohol-induced neuroinflammation

  99. 2021

    Role of marijuana components on the regenerative ability of stem cells

    FavorávelEstudo LaboratorialCicatrização
  100. 2021

    Role of PI3K/Akt axis in mitigating hippocampal ischemia-reperfusion injury via CB1 receptor stimulation by paracetamol and FAAH inhibitor in rat

    FavorávelEstudo em AnimaisAVCCOVID-19Anandamida (AEA)Endocanabinoide (não especificado)+1